Extracorporeal Photopheresis: Secreted Factors That Promote Immunomodulation.

Area of Science:

• Immunology
• Cell Biology
• Therapeutics

Background:

• Extracorporeal photopheresis (ECP) treats T cell-mediated conditions like CTCL, GVHD, and transplant rejection.
• ECP involves treating leukocytes with 8-methoxypsoralen and UVA light, followed by reinfusion.
• ECP has immune-stimulatory effects in CTCL and immune regulatory effects in GVHD and transplant rejection.

Purpose of the Study:

• To review the literature on ECP-induced secreted factors.
• To understand the immunomodulatory roles of these secreted factors.

Main Methods:

• Comprehensive literature review.
• Analysis of ECP-induced changes in leukocyte apoptosis, cytokine production, and dendritic cell maturation.

Main Results:

• ECP induces leukocyte apoptosis and release of damage-associated molecular patterns.
• In CTCL, ECP increases pro-inflammatory cytokines (IFN-γ, IL-2, TNF-α, IL-1β, IL-8) linked to antitumor responses.
• In GVHD and transplant rejection, ECP promotes anti-inflammatory cytokines (IL-10, TGF-β, IL-4, IL-13), leading to tolerogenic dendritic cells and reduced rejection.

Conclusions:

• ECP induces condition-specific release of pro- or anti-inflammatory factors.
• These factors influence dendritic cell maturation and immunomodulatory effects.
• Further multi-omics research is needed to fully elucidate the ECP-induced secretome.